Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia

Clinical trial NCT01518556 · COMPLETED

Trial details

NCT number: NCT01518556
Sponsor: Konkuk University Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2011-07-01
Primary completion: 2025-03-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.